PNS Safety & Peripheral Neuropathy Assessment

About 28Bio

28Bio is a private, preclinical-stage biotech leveraging its proprietary Nexon™ platform to create engineered human brain and peripheral nervous system organoids for neurotoxicity and efficacy testing. The company's technology, which combines 3D tissue engineering, embedded neural electrodes, and AI-driven analysis, has demonstrated superior predictive performance compared to animal models, as evidenced by its retrospective Endurance Study. 28Bio operates primarily as a platform and services company, offering predictive assays to pharmaceutical partners to de-risk neurological drug development, and is currently in a pre-revenue stage.

Therapeutic Areas